Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true? Guidotti LG, La Vecchia C, Colombo M. Hepatology 2022;76:300-302.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guidotti LG, La Vecchia C, Colombo M. Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true? Hepatology 2022;76:300-302.
PMID: 35254662